| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 22,235 | 16,676 | 5,559 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| MERRILL LYNCH SECURITIES | FMV | 4,878,950 | 8,570,945 |
| ADVANCED EQUITIES INVESTMENTS | AT COST | 15,000 | 15,000 |
| IVP CALIENT, LLC | AT COST | 15,962 | 15,962 |
| FRANCISCO PARTNERS INVESTMENTS | AT COST | 436,863 | 436,863 |
| CALIENT HOLDINGS | AT COST | 37,489 | 37,489 |
| INTUITIVE CALIENT II, LLC | AT COST | 109,933 | 109,933 |
| CYTORI OFFERING | AT COST | 72,300 | 72,300 |
| INVESTMENT - NEUROTROPE BIO SCIENCE INC | AT COST | 108,000 | 108,000 |
| INVESTMENT - ESKSO BIONICS | AT COST | 40,000 | 40,000 |
| INVESTMENT - NEXTLEVEL SECURITY SYSTEMS | AT COST | 25,000 | 25,000 |
| INVESTMENT - PIERIS PHARMACEUTICALS INC | AT COST | 7,759 | 7,759 |
| INVESTMENT - CUR | AT COST | 20,000 | 20,000 |
| INVESTMENT - ENUMERAL EDI | AT COST | 25,000 | 25,000 |
| US VENTURE PARTNERS XI | AT COST | 170,518 | 170,518 |
| INTUITIVE PEERNOVA | AT COST | 110,727 | 110,727 |
| MEDIA | AT COST | 5,000 | 5,000 |
| HISTOGEN INC | AT COST | 30,396 | 30,396 |
| WILSON SONSINI CALIENT | AT COST | 502,750 | 502,750 |
| INTUITIVE INCODEMA 3D | AT COST | 87,359 | 87,359 |
| SPRUCE DIRECT | AT COST | 4,718 | 4,718 |
| ORPHEUS BIOSCIENCE INC | AT COST | 20,000 | 20,000 |
| INNOVATE BIOPHARMACEUTICALS | AT COST | 8,755 | 8,755 |
| INVESTMENT - US VENTURES XII | AT COST | 257,014 | 257,014 |
| INTUITIVE HZO II, LLC | AT COST | 9,912 | 9,912 |
| OPTICAL CIRCUIT TECH COMPANY | AT COST | 69,079 | 69,079 |
| BLOCK CHANGE TECHNOLOGY | AT COST | 25,000 | 25,000 |
| GROGURU | AT COST | 30,000 | 30,000 |
| CARLSMED INC | AT COST | 25,000 | 25,000 |
| INTUITIVE OSTENDO LLC | AT COST | 24,871 | 24,871 |
| INTUIT 19578 | AT COST | 10,000 | 10,000 |
| INTUITIVE HZO III, LLC | AT COST | 11,104 | 11,104 |
| US VENTURE PARTNERS XIII | AT COST | 66,515 | 66,515 |
| GEMINI SPACE STATION | AT COST | 37,762 | 37,762 |
| Description | Amount |
|---|---|
| UNREALIZED GAINS/(LOSSES) | 812,429 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| MISCELLANEOUS | 23,326 | 0 | 0 | |
| K-1 INVESTMENT LOSSES | 22,462 | 22,462 | 0 | |
| INTEREST EXPENSE | 161 | 0 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| OTHER INCOME | 2,747 | 2,747 | 2,747 |
| Description | Beginning of Year - Book Value | End of Year - Book Value |
|---|---|---|
| INVESTMENT IN ICHOR HOLDINGS | 6,330 | 6,330 |
| INVESTMENT IN QUANTIAMD, LLC | 83,548 | 83,548 |
| INVESTMENT IN ANGION BIOMEDICA CORP | 20 | 20 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INVESTMENT FEES | 83,130 | 83,130 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAX PAID | 2,454 | 2,454 | 0 | |
| FEDERAL TAX | 10,894 | 0 | 0 |